MAR 13, 2019 11:50 AM PDT

Innovative Neurotechnologies: NIH Funding for Technology Development and Translation to Humans

Presented at: Neuroscience 2019
  • Program Director, Division of Translational Research, National Institute of Neurological Disorders and Stroke (NINDS)
      Nick B. Langhals, Ph.D. serves as a Program Director within the Division of Translational Research at the National Institute of Neurological Disorders and Stroke (NINDS). Nick Langhals is a team lead in both the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative as well as the Stimulating Peripheral Activity to Relieve Conditions (SPARC) program, and is a Program Lead with the Helping to End Addiction Long-term (HEAL) Initiative. He currently manages a grant portfolio in the areas of neurotechnology development, validation, and translation for applications in neuroscience, neurophysiology, movement disorders, pain, neuromodulation, and other interfaces with the nervous system. Dr. Langhals received his Bachelor of Science in Engineering (B.S.E. - 2001) from Arizona State University (Tempe, AZ). He received both a Master of Science in Engineering (M.S.E. - 2003) as well as a Doctor of Philosophy (Ph.D. - 2010) in Biomedical Engineering from the University of Michigan (Ann Arbor, MI). Prior to arriving at the NIH in 2015, Dr. Langhals served as a Research Assistant Professor in Plastic Surgery and Biomedical Engineering at the University of Michigan and Co-Director of the Neuromuscular Laboratory. Dr. Langhals has worked as a Senior Research Engineer within the Center for Neural Communication Technology, served as a consultant for Neuronexus Technologies (Ann Arbor, MI), Biotectix (Ann Arbor, MI), Michigan State University (East Lansing, MI), and was also co-founder of Rhythm Solutions.


    This talk provides a brief overview of funding opportunities for invasive device development for translation to clinical populations supported by the NIH BRAIN Initiative.

    Show Resources
    Show Resources